Medical management of benign prostatic hypertrophy.
作者信息
Geller J
机构信息
Research Department, Mercy Hospital and Medical Center, San Diego, CA 92103.
出版信息
Compr Ther. 1994;20(12):682-7.
PMID:7533690
Abstract
摘要
相似文献
1
Medical management of benign prostatic hypertrophy.良性前列腺增生的医学管理。
Compr Ther. 1994;20(12):682-7.
2
What is the best medical treatment for benign prostate hyperplasia?良性前列腺增生的最佳医学治疗方法是什么？
Can Fam Physician. 1997 Jun;43:1073-4.
3
[5-alpha reductase inhibitors plus alpha blockers. A combination therapy keeps a common disease checked].[5α还原酶抑制剂加α受体阻滞剂。联合疗法控制常见疾病]
MMW Fortschr Med. 2003 Jul 10;145(27-28):58-9.
4
Medical management of benign prostatic hyperplasia--are two drugs better than one?良性前列腺增生的药物治疗——两种药物比一种更好吗？
N Engl J Med. 2003 Dec 18;349(25):2449-51. doi: 10.1056/NEJMe038154.
5
Optimising the medical management of benign prostatic hyperplasia.
Br J Clin Pract. 1997 Mar;51(2):116-8.
6
Finasteride in benign prostatic hyperplasia.非那雄胺治疗良性前列腺增生症
N Engl J Med. 2004 Mar 25;350(13):1359-61; author reply 1359-61.
7
[5-alpha reductase inhibitors or alpha blockers? The combination brakes best prostatic hyperplasia].5α还原酶抑制剂还是α受体阻滞剂？联合使用对前列腺增生的治疗效果最佳
MMW Fortschr Med. 2002 Oct 31;144(44):56.
8
[A trial of the use of finasteride and terazosin in patients with benign prostatic hyperplasia].
Urol Nefrol (Mosk). 1995 Jul-Aug(4):32-5.
9
[Drug treatment of benign prostatic hyperplasia].
Praxis (Bern 1994). 1995 Sep 26;84(39):1061-2.
10
[The tested combination is recommended. Are 5-alpha reductase inhibitors interchangeable?].
MMW Fortschr Med. 2003 Jul 10;145(27-28):59.
Zotero 插件